Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Photosensitizer Verteporfin Has Light-Independent Anti-Leukemic Activity for Ph-Positive Acute Lymphoblastic Leukemia and Synergistically Works with Dasatinib in Vivo

Takanobu Morishita, MD, Fumihiko Hayakawa, MD PhD, Keiki Sugimoto, PhD, Daiki Hirano, MD, Yuki Kojima, MD, Naoto Imoto, MD, Yuichiro Inagaki, MD, Tomoki Naoe, MDPhD, Hitoshi Kiyoi, MD PhD

Blood (2015) 126 (23): 1331.

https://doi.org/10.1182/blood.V126.23.1331.1331

Published: 2015

Journal Articles

Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

Denis-Claude Roy, MD, Johan Maertens, MD PhD, Irwin Walker, MBBS, Silvy Lachance, MD, Jean Roy, MD, Stephen Ronan Foley, MD, Philippe Lewalle, MD PhD, Dominik L.D. Selleslag, MD, Liesbeth De Jong, PhD, Jurjen H.L. Velthuis, PhD, Lisya Gerez, PhD, Karen Reitsma, PhD, Edwin Wagena, PhD, Stephan Mielke, MD

Blood (2014) 124 (21): 314.

https://doi.org/10.1182/blood.V124.21.314.314

Published: 2014

Journal Articles

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Valentina Rapozzi, Ph.D, Sara Huerta-Yepez, PhD, Abhijeet Joshi, Mario I. Vega, PhD, Stavroula Baritaki, PhD, Luigi E. Xodo, Ph.D, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 5113.

https://doi.org/10.1182/blood.V116.21.5113.5113

Published: 2010

Journal Articles

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Serena Rupoli, MD, Nicola Pimpinelli, MD, Gaia Goteri, MD, Lucia Canafoglia, MD, Paola Picardi, Giuliano Brandozzi, MD, Stefano Pulini, Irene Federici, PhD, Anna Rita Scortechini, md, Simona Tomassetti, MD, Lisa Albani, MD, Lidia Da Lio, MD, Mirella Giangiacomi, Pietro Leoni, MD

Blood (2010) 116 (21): 3953.

https://doi.org/10.1182/blood.V116.21.3953.3953

Published: 2010

Journal Articles

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

Si mcha Samuel, Lola Weiss, Osnat Hazan, Igor B Resnick, Michael Y. Shapira, MD, Benjamin Gesundheit, Lilane Dray, Reuven Or

Blood (2008) 112 (11): 4618.

https://doi.org/10.1182/blood.V112.11.4618.4618

Published: 2008

Journal Articles

Anti-Chronic Graft Versus Host Disease Activity Though a Regulatory T Cell Dependent Mechanism after Photodynamic Therapy.

Jean-Philippe Bastien, Gorazd Krosl, Pascale Dube, Cynthia Therien, Christian Scotto, Denis-Claude Roy

Blood (2007) 110 (11): 3280.

https://doi.org/10.1182/blood.V110.11.3280.3280

Published: 2007

Journal Articles

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2007) 110 (11): 2976.

https://doi.org/10.1182/blood.V110.11.2976.2976

Published: 2007

Journal Articles

Photopheresis in HIV-1 Infected Patients (Pt) Using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Cytolytic T-Cell Activity, Intracellular Expression of Chemokines, and Decreases HIV Infectivity and Viral Load.

Zale P. Bernstein, MD, Thomas Dougherty, Stanley Schwartz, Sandra Gollnick, Carleton Stewart, Harold Walder, M.P.N. Nair, S.D. Mahajan, Adam Sumlin, Bernard Poiesz

Blood (2006) 108 (11): 1257.

https://doi.org/10.1182/blood.V108.11.1257.1257

Published: 2006

Journal Articles

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2006) 108 (11): 309.

https://doi.org/10.1182/blood.V108.11.309.309

Published: 2006

Journal Articles

A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.

David Allan, MD, Robert Belanger, MD, Lambert Busque, MD, Douglas Fish, MD, Jeannine Kassis, MD, Jean Roy, MD, Claude Perreault, MD, Denis-Claude Roy, MD

Blood (2005) 106 (11): 2201.

https://doi.org/10.1182/blood.V106.11.2201.2201

Published: 2005

Journal Articles

Photopheresis in HIV-1 Infected Patients (pt) Using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Intracellular Expression of Chemokines and Decreases HIV Infectivity and Viral Load.

Zale P. Bernstein, MD, Thomas Dougherty, Stanley A. Schwartz, MD, Sandra Gollnick, Carlton Stewart, MD, Harold Walder, M. P. Nair, S. D. Mahajan, Adam Sumlin, Patricia Marhsall, Bernard Poiesz, MD

Blood (2005) 106 (11): 1431.

https://doi.org/10.1182/blood.V106.11.1431.1431

Published: 2005

Journal Articles

A Photodynamic Pathway to Apoptosis Induced by Hypericin in Human Myeloma ARH-77 Cell Line: Possible Relevance to Photodynamic Therapy.

Ferit Avcu, MD, Ali U. Ural, MD, Yusuf Baran, PhD, Gungor Sobaci, MD, Mustafa Deveci, MD, Turker Cetin, MD, Aysel Pekel, MsC, Meral Sarper, MsC, Pinar Elci, MsC, Ufuk Gunduz, PhD

Blood (2005) 106 (11): 5076.

https://doi.org/10.1182/blood.V106.11.5076.5076

Published: 2005

Journal Articles

Photopheresis in HIV-1 Infected Patients (pt) using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Intracellular Expression of Chemokines and Decreases HIV Infectivity and Viral Load.

Zale P. Bernstein, MD, Thomas Dougherty, Ph.D., Stanley A. Schwartz, MD, Sandra Gollnick, Ph.D., Carleton Stewart, Ph.D., Harold Walder, M. P. Nair, Supriya D. Mahajan, Adam Sumlin, Bernard J. Poiesz, MD

Blood (2004) 104 (11): 3836.

https://doi.org/10.1182/blood.V104.11.3836.3836

Published: 2004

Journal Articles

Preferential Induction of B Cell Apoptosis Using Photodynamic Therapy.

Gorazd Krosl, Ph.D., Pascale Dube, Nancy Dallaire, M.Sc., Marc Vaillancourt, Ph.D., Denis-Claude Roy, M.D.

Blood (2004) 104 (11): 4643.

https://doi.org/10.1182/blood.V104.11.4643.4643

Published: 2004

Journal Articles

Specific Elimination of Alloreactive T Lymphocytes Using Photodynamic Therapy Prevents GVHD and Enables Rapid Immune Reconstitution.

Radia Sidi Boumedine, B.Sc., Gorazd Krosl, Ph.D., Marc Vaillancourt, Ph.D., Claude Perreault, M.D., Denis-Claude Roy, M.D.

Blood (2004) 104 (11): 4987.

https://doi.org/10.1182/blood.V104.11.4987.4987

Published: 2004

Journal Articles

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

D. J. Granville, C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J.-Y. Matroule, J. Piette, D. W. C. Hunt

Blood (2000) 95 (1): 256–262.

https://doi.org/10.1182/blood.V95.1.256

Published: 2000

Journal Articles

Prospective Randomized Multicenter Clinical Trial on the Use of Interferon -2a Plus Acitretin Versus Interferon -2a Plus PUVA in Patients With Cutaneous T-Cell Lymphoma Stages I and II

R. Stadler, H.-G. Otte, T. Luger, B.M. Henz, P. Kühl, T. Zwingers, W. Sterry

Blood (1998) 92 (10): 3578–3581.

https://doi.org/10.1182/blood.V92.10.3578

Published: 1998

NARROW

A Photosensitizer Verteporfin Has Light-Independent Anti-Leukemic Activity for Ph-Positive Acute Lymphoblastic Leukemia and Synergistically Works with Dasatinib in Vivo

Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

Anti-Chronic Graft Versus Host Disease Activity Though a Regulatory T Cell Dependent Mechanism after Photodynamic Therapy.

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Photopheresis in HIV-1 Infected Patients (Pt) Using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Cytolytic T-Cell Activity, Intracellular Expression of Chemokines, and Decreases HIV Infectivity and Viral Load.

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.

Photopheresis in HIV-1 Infected Patients (pt) Using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Intracellular Expression of Chemokines and Decreases HIV Infectivity and Viral Load.

A Photodynamic Pathway to Apoptosis Induced by Hypericin in Human Myeloma ARH-77 Cell Line: Possible Relevance to Photodynamic Therapy.

Photopheresis in HIV-1 Infected Patients (pt) using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Intracellular Expression of Chemokines and Decreases HIV Infectivity and Viral Load.

Preferential Induction of B Cell Apoptosis Using Photodynamic Therapy.

Specific Elimination of Alloreactive T Lymphocytes Using Photodynamic Therapy Prevents GVHD and Enables Rapid Immune Reconstitution.

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

Prospective Randomized Multicenter Clinical Trial on the Use of Interferon -2a Plus Acitretin Versus Interferon -2a Plus PUVA in Patients With Cutaneous T-Cell Lymphoma Stages I and II

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only